Teleflex's Third Quarter Profit: A Surge in Medical Devices Demand

Friday, 1 November 2024, 05:13

Teleflex's third quarter profit exceeded expectations due to strong demand for its medical devices. Key products driving this performance include vascular access devices and other surgical equipment. As the demand for non-urgent procedures rises among older adults, medical device companies like Boston Scientific and Stryker benefit significantly, resulting in improved forecasts. CEO Liam Kelly highlighted the positive impact of robust sales in bloodstream-related products on overall revenue.
Indiatimes
Teleflex's Third Quarter Profit: A Surge in Medical Devices Demand

Teleflex's Robust Financial Performance

Teleflex, a leading manufacturer of surgical equipment, has reported a better-than-expected profit for the third quarter. The results were driven by a strong demand for its medical devices, especially amid the rising need for non-urgent procedures among older adults. Teleflex’s revenue increased by 2.4%, reaching $764.4 million, though slightly missing analysts' expectations.

Key Contributors to Teleflex's Success

  • Strong sales in bloodstream-related products.
  • Growth in heart and medical imaging devices.
  • Backing from consistent investor expectations, influenced by peers like Boston Scientific and Stryker.

CEO Liam Kelly noted that despite the revenue miss, the company’s focus on vascular access and other essential medical devices continues to support overall performance and outlook.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Subscribe to our newsletter for the most accurate and current medical news. Stay updated and deepen your understanding of medical advancements effortlessly.

Subscribe